Related Experiment Video

Updated: Aug 16, 2026

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

Demethylation of DNA by decitabine in cancer chemotherapy

Robert Brown1, Jane A Plumb

  • 1Cancer Research UK Beatson Laboratories, Centre for Oncology and Applied Pharmacology, Glasgow University, Glasgow G61 1BD, UK. R.Brown@Beatson.gla.ac.uk

Expert Review of Anticancer Therapy
|July 24, 2004
PubMed

Insights

Decitabine, a DNA methyltransferase inhibitor, shows antitumor activity by reversing epigenetic silencing and reactivating tumor suppressor genes. This epigenetic therapy may be best used at lower doses, potentially in combination with other treatments.

Area of Science:

  • Oncology
  • Epigenetics
  • Pharmacology

Background:

  • Aberrant gene methylation is common in tumor cells, affecting critical processes like apoptosis and cell cycle regulation.
  • Epigenetic silencing of tumor suppressor genes contributes to cancer development and growth.

Purpose of the Study:

  • To investigate the potential of decitabine (2'-deoxy-5-azacytidine) as a DNA methyltransferase inhibitor for cancer therapy.
  • To explore the mechanism of decitabine in reversing epigenetic silencing and reactivating tumor suppressor genes.

Main Methods:

  • Decitabine, a nucleoside analog, was studied for its ability to inhibit DNA methyltransferases.
  • The study considered the effects of decitabine on gene methylation patterns and tumor suppressor gene activity.

Main Results:

  • Decitabine demonstrated antitumor activity, particularly in hematologic malignancies.
  • The drug can reverse aberrant methylation, leading to the potential reactivation of tumor suppressor genes.

Conclusions:

  • Decitabine's mechanism involves inhibiting DNA methyltransferases and reversing epigenetic silencing.
  • Optimal use of decitabine may involve lower doses than maximum tolerated doses, focusing on demethylating activity.
  • Synergistic potential with other epigenetic therapies and chemotherapies suggests rational combination strategies.

More Related Videos

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C11:53

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C

Published on: June 1, 2018

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...